(+)-schisandrin B multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABHD2 mRNA] CTD PMID:31150632 1,2-dimethylhydrazine decreases expression ISO RGD:1322826 6480464 1, 2-Dimethylhydrazine results in decreased expression of ABHD2 mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression ISO RGD:1322826 6480464 Ethinyl Estradiol results in increased expression of ABHD2 mRNA CTD PMID:17942748 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of ABHD2 mRNA CTD PMID:29097150 17beta-estradiol multiple interactions ISO RGD:1322825 6480464 EGF protein promotes the reaction [Estradiol results in increased expression of ABHD2 mRNA] CTD PMID:24758408 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of ABHD2 mRNA CTD PMID:35192832 17beta-estradiol increases expression ISO RGD:1322825 6480464 Estradiol results in increased expression of ABHD2 mRNA CTD PMID:24758408 more ... 17beta-hydroxy-5alpha-androstan-3-one increases expression ISO RGD:1322825 6480464 Dihydrotestosterone results in increased expression of ABHD2 mRNA CTD PMID:29581250 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1322825 6480464 2 more ... CTD PMID:23146750 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO RGD:1322825 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1322826 6480464 Tetrachlorodibenzodioxin affects the expression of ABHD2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of ABHD2 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1322826 6480464 Tetrachlorodibenzodioxin results in decreased expression of ABHD2 mRNA CTD PMID:33956508 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1322825 6480464 Tetrachlorodibenzodioxin results in increased expression of ABHD2 mRNA CTD PMID:20106945 , PMID:21632981 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of ABHD2 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of ABHD2 mRNA CTD PMID:21346803 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of ABHD2 mRNA CTD PMID:28522335 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1322825 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ABHD2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABHD2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO RGD:1322825 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ABHD2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1322825 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of ABHD2 gene CTD PMID:31601247 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of ABHD2 mRNA CTD PMID:24780913 acetamide decreases expression EXP 6480464 acetamide results in decreased expression of ABHD2 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO RGD:1322826 6480464 Aflatoxin B1 results in increased expression of ABHD2 mRNA CTD PMID:19770486 aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of ABHD2 mRNA CTD PMID:33354967 aflatoxin B1 increases methylation ISO RGD:1322825 6480464 Aflatoxin B1 results in increased methylation of ABHD2 intron CTD PMID:30157460 all-trans-retinoic acid increases expression ISO RGD:1322825 6480464 Tretinoin results in increased expression of ABHD2 mRNA CTD PMID:33167477 arsenite(3-) multiple interactions ISO RGD:1322825 6480464 arsenite inhibits the reaction [G3BP1 protein binds to ABHD2 mRNA] CTD PMID:32406909 atrazine affects methylation EXP 6480464 Atrazine affects the methylation of ABHD2 gene CTD PMID:28931070 benzo[a]pyrene increases expression ISO RGD:1322826 6480464 Benzo(a)pyrene results in increased expression of ABHD2 mRNA CTD PMID:21569818 benzo[a]pyrene decreases methylation ISO RGD:1322825 6480464 Benzo(a)pyrene results in decreased methylation of ABHD2 3' UTR CTD PMID:27901495 benzo[a]pyrene increases methylation ISO RGD:1322825 6480464 Benzo(a)pyrene results in increased methylation of ABHD2 5' UTR CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:1322826 6480464 Benzo(a)pyrene results in decreased methylation of ABHD2 intron CTD PMID:27901495 benzo[a]pyrene decreases expression ISO RGD:1322826 6480464 Benzo(a)pyrene results in decreased expression of ABHD2 mRNA CTD PMID:20127859 benzo[a]pyrene decreases expression ISO RGD:1322825 6480464 Benzo(a)pyrene results in decreased expression of ABHD2 mRNA CTD PMID:20064835 , PMID:32234424 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:1322825 6480464 7 more ... CTD PMID:19150397 , PMID:20018196 bis(2-ethylhexyl) phthalate increases expression ISO RGD:1322826 6480464 Diethylhexyl Phthalate results in increased expression of ABHD2 mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1322826 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in increased expression of ABHD2 mRNA] CTD PMID:19850644 bisphenol A increases expression ISO RGD:1322825 6480464 bisphenol A results in increased expression of ABHD2 mRNA CTD PMID:20678512 , PMID:28711546 bisphenol A increases expression ISO RGD:1322826 6480464 bisphenol A results in increased expression of ABHD2 mRNA CTD PMID:32370801 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of ABHD2 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of ABHD2 gene CTD PMID:28505145 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of ABHD2 mRNA CTD PMID:29097150 more ... bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of ABHD2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1322825 6480464 bisphenol A results in decreased expression of ABHD2 mRNA CTD PMID:23146750 bisphenol F multiple interactions ISO RGD:1322825 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABHD2 mRNA CTD PMID:28628672 bortezomib increases expression ISO RGD:1322825 6480464 Bortezomib results in increased expression of ABHD2 mRNA CTD PMID:20977926 butanal decreases expression ISO RGD:1322825 6480464 butyraldehyde results in decreased expression of ABHD2 mRNA CTD PMID:26079696 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of ABHD2 mRNA CTD PMID:22110744 caffeine increases phosphorylation ISO RGD:1322825 6480464 Caffeine results in increased phosphorylation of ABHD2 protein CTD PMID:35688186 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of ABHD2 mRNA CTD PMID:20211217 carbon nanotube increases expression ISO RGD:1322826 6480464 Nanotubes, Carbon results in increased expression of ABHD2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1322825 6480464 CGP 52608 promotes the reaction [RORA protein binds to ABHD2 gene] CTD PMID:28238834 chlordecone increases expression ISO RGD:1322826 6480464 Chlordecone results in increased expression of ABHD2 mRNA CTD PMID:33711761 choline multiple interactions ISO RGD:1322826 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ABHD2 mRNA more ... CTD PMID:20938992 more ... cisplatin affects response to substance ISO RGD:1322825 6480464 ABHD2 protein affects the susceptibility to Cisplatin CTD PMID:16217747 clomiphene decreases expression ISO RGD:1322825 6480464 Clomiphene results in decreased expression of ABHD2 mRNA CTD PMID:26865669 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of ABHD2 mRNA CTD PMID:24386269 copper(II) sulfate increases expression ISO RGD:1322825 6480464 Copper Sulfate results in increased expression of ABHD2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1322825 6480464 Asbestos, Crocidolite results in increased expression of ABHD2 mRNA CTD PMID:18687144 crocidolite asbestos multiple interactions ISO RGD:1322826 6480464 Asbestos, Crocidolite inhibits the reaction [SPARC gene mutant form results in increased expression of ABHD2 mRNA] CTD PMID:19446018 crocidolite asbestos increases expression ISO RGD:1322826 6480464 Asbestos, Crocidolite results in increased expression of ABHD2 mRNA CTD PMID:19446018 cyclosporin A decreases expression ISO RGD:1322825 6480464 Cyclosporine results in decreased expression of ABHD2 mRNA CTD PMID:20106945 decabromodiphenyl ether increases expression EXP 6480464 decabromobiphenyl ether results in increased expression of ABHD2 mRNA CTD PMID:23640034 dexamethasone multiple interactions ISO RGD:1322825 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ABHD2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABHD2 mRNA CTD PMID:28628672 diazinon increases methylation ISO RGD:1322825 6480464 Diazinon results in increased methylation of ABHD2 gene CTD PMID:22964155 diethylstilbestrol increases expression ISO RGD:1322825 6480464 Diethylstilbestrol results in increased expression of ABHD2 mRNA CTD PMID:26865669 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of ABHD2 mRNA CTD PMID:33729688 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of ABHD2 mRNA CTD PMID:20211217 elemental selenium increases expression ISO RGD:1322825 6480464 Selenium results in increased expression of ABHD2 mRNA CTD PMID:19244175 Enterolactone decreases expression ISO RGD:1322825 6480464 2, 3-bis(3'-hydroxybenzyl)butyrolactone results in decreased expression of ABHD2 mRNA CTD PMID:19167446 estrone increases expression ISO RGD:1322825 6480464 Estrone results in increased expression of ABHD2 mRNA CTD PMID:26865669 ethanol increases expression ISO RGD:1322826 6480464 Ethanol results in increased expression of ABHD2 mRNA CTD PMID:30319688 ethyl methanesulfonate increases expression ISO RGD:1322825 6480464 Ethyl Methanesulfonate results in increased expression of ABHD2 mRNA CTD PMID:23649840 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of ABHD2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1322826 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ABHD2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABHD2 mRNA CTD PMID:20938992 , PMID:29127188 formaldehyde increases expression ISO RGD:1322825 6480464 Formaldehyde results in increased expression of ABHD2 mRNA CTD PMID:23649840 fulvestrant decreases expression ISO RGD:1322825 6480464 fulvestrant results in decreased expression of ABHD2 mRNA CTD PMID:26865669 furan increases expression ISO RGD:1322826 6480464 furan results in increased expression of ABHD2 mRNA CTD PMID:24183702 furan decreases expression EXP 6480464 furan results in decreased expression of ABHD2 mRNA CTD PMID:25539665 genistein increases expression ISO RGD:1322825 6480464 Genistein results in increased expression of ABHD2 mRNA CTD PMID:26865669 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of ABHD2 mRNA CTD PMID:22061828 , PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of ABHD2 mRNA CTD PMID:24136188 glyphosate increases expression ISO RGD:1322825 6480464 glyphosate results in increased expression of ABHD2 mRNA CTD PMID:28711546 hexestrol increases expression ISO RGD:1322825 6480464 Hexestrol results in increased expression of ABHD2 mRNA CTD PMID:26865669 indole-3-methanol affects expression EXP 6480464 indole-3-carbinol affects the expression of ABHD2 mRNA CTD PMID:21396975 indometacin multiple interactions ISO RGD:1322825 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of ABHD2 mRNA, [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of ABHD2 mRNA CTD PMID:28628672 inulin multiple interactions ISO RGD:1322826 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ABHD2 mRNA CTD PMID:36331819 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of ABHD2 mRNA CTD PMID:20211217 L-methionine multiple interactions ISO RGD:1322826 6480464 [Choline deficiency co-treated with Folic Acid deficiency co-treated with Methionine deficiency] results in increased expression of ABHD2 mRNA, [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of ABHD2 mRNA CTD PMID:20938992 , PMID:29127188 lead(0) affects expression ISO RGD:1322825 6480464 Lead affects the expression of ABHD2 mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:1322825 6480464 Lead affects the expression of ABHD2 mRNA CTD PMID:28903495 leflunomide decreases expression EXP 6480464 leflunomide results in decreased expression of ABHD2 mRNA CTD PMID:24136188 mestranol increases expression ISO RGD:1322825 6480464 Mestranol results in increased expression of ABHD2 mRNA CTD PMID:26865669 methotrexate affects expression ISO RGD:1322826 6480464 Methotrexate affects the expression of ABHD2 mRNA CTD PMID:18502557 methyl methanesulfonate increases expression ISO RGD:1322825 6480464 Methyl Methanesulfonate results in increased expression of ABHD2 mRNA CTD PMID:23649840 N-nitrosodiethylamine increases expression ISO RGD:1322826 6480464 Diethylnitrosamine results in increased expression of ABHD2 mRNA CTD PMID:24535843 nefazodone decreases expression EXP 6480464 nefazodone results in decreased expression of ABHD2 mRNA CTD PMID:24136188 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of ABHD2 mRNA CTD PMID:26720608 O-methyleugenol decreases expression ISO RGD:1322825 6480464 methyleugenol results in decreased expression of ABHD2 mRNA CTD PMID:32234424 paracetamol affects expression ISO RGD:1322826 6480464 Acetaminophen affects the expression of ABHD2 mRNA CTD PMID:17562736 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of ABHD2 mRNA CTD PMID:33387578 paracetamol increases expression ISO RGD:1322825 6480464 Acetaminophen results in increased expression of ABHD2 mRNA CTD PMID:22230336 paracetamol decreases expression ISO RGD:1322825 6480464 Acetaminophen results in decreased expression of ABHD2 mRNA CTD PMID:21420995 , PMID:29067470 paraquat increases expression EXP 6480464 Paraquat results in increased expression of ABHD2 mRNA CTD PMID:32680482 parathion increases expression ISO RGD:1322826 6480464 Parathion results in increased expression of ABHD2 mRNA CTD PMID:34813904 perfluorooctane-1-sulfonic acid multiple interactions ISO RGD:1322826 6480464 [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of ABHD2 mRNA CTD PMID:36331819 phenobarbital multiple interactions ISO RGD:1322826 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of ABHD2 mRNA] CTD PMID:19482888 phenobarbital increases expression ISO RGD:1322826 6480464 Phenobarbital results in increased expression of ABHD2 mRNA CTD PMID:19482888 phenylephrine increases expression EXP 6480464 Phenylephrine results in increased expression of ABHD2 mRNA CTD PMID:18158353 picene decreases expression ISO RGD:1322825 6480464 picene results in decreased expression of ABHD2 mRNA CTD PMID:32251684 pirinixic acid multiple interactions ISO RGD:1322826 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of ABHD2 mRNA, [pirinixic acid co-treated with PPARA] results in increased expression of ABHD2 mRNA CTD PMID:19710929 , PMID:20813756 pirinixic acid increases expression ISO RGD:1322826 6480464 pirinixic acid results in increased expression of ABHD2 mRNA CTD PMID:18301758 more ... pirinixic acid multiple interactions ISO RGD:1322825 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of ABHD2 mRNA CTD PMID:19710929 poly(I:C) multiple interactions EXP 6480464 [Poly I-C co-treated with HU 211] results in decreased expression of ABHD2 mRNA CTD PMID:26923065 potassium chromate decreases expression ISO RGD:1322825 6480464 potassium chromate(VI) results in decreased expression of ABHD2 mRNA CTD PMID:22714537 raloxifene decreases expression ISO RGD:1322825 6480464 Raloxifene Hydrochloride results in decreased expression of ABHD2 mRNA CTD PMID:26865669 rotenone affects expression EXP 6480464 Rotenone affects the expression of ABHD2 mRNA CTD PMID:28374803 selenium atom increases expression ISO RGD:1322825 6480464 Selenium results in increased expression of ABHD2 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO RGD:1322825 6480464 Silicon Dioxide analog results in increased expression of ABHD2 mRNA CTD PMID:23806026 sodium arsenite affects expression ISO RGD:1322825 6480464 sodium arsenite affects the expression of ABHD2 mRNA CTD PMID:29319823 streptozocin multiple interactions ISO RGD:1322826 6480464 [Streptozocin co-treated with Dietary Fats] results in increased expression of ABHD2 mRNA CTD PMID:29127188 sunitinib decreases expression ISO RGD:1322825 6480464 Sunitinib results in decreased expression of ABHD2 mRNA CTD PMID:31533062 tamoxifen decreases expression ISO RGD:1322826 6480464 Tamoxifen results in decreased expression of ABHD2 mRNA CTD PMID:25123088 testosterone enanthate affects expression ISO RGD:1322825 6480464 testosterone enanthate affects the expression of ABHD2 mRNA CTD PMID:17440010 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of ABHD2 mRNA CTD PMID:31150632 tetrachloromethane increases expression ISO RGD:1322826 6480464 Carbon Tetrachloride results in increased expression of ABHD2 mRNA CTD PMID:29987408 , PMID:31919559 tetrachloromethane multiple interactions EXP 6480464 schizandrin B inhibits the reaction [Carbon Tetrachloride results in decreased expression of ABHD2 mRNA] CTD PMID:31150632 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of ABHD2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1322826 6480464 titanium dioxide results in increased expression of ABHD2 mRNA CTD PMID:27760801 trichostatin A affects expression ISO RGD:1322825 6480464 trichostatin A affects the expression of ABHD2 mRNA CTD PMID:28542535 trimellitic anhydride increases expression ISO RGD:1322826 6480464 trimellitic anhydride results in increased expression of ABHD2 mRNA CTD PMID:19042947 Triptolide increases expression ISO RGD:1322826 6480464 triptolide results in increased expression of ABHD2 mRNA CTD PMID:32835833 valproic acid decreases methylation ISO RGD:1322825 6480464 Valproic Acid results in decreased methylation of ABHD2 gene CTD PMID:29154799 valproic acid increases expression ISO RGD:1322825 6480464 Valproic Acid results in increased expression of ABHD2 mRNA CTD PMID:23179753 , PMID:27188386 valproic acid affects expression ISO RGD:1322825 6480464 Valproic Acid affects the expression of ABHD2 mRNA CTD PMID:25979313 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of ABHD2 mRNA CTD PMID:23034163 vitamin E decreases expression ISO RGD:1322825 6480464 Vitamin E results in decreased expression of ABHD2 mRNA CTD PMID:19244175 vitamin E increases expression ISO RGD:1322825 6480464 Vitamin E results in increased expression of ABHD2 mRNA CTD PMID:19244175 zinc atom multiple interactions ISO RGD:1322825 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ABHD2 mRNA CTD PMID:18593933 zinc(0) multiple interactions ISO RGD:1322825 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of ABHD2 mRNA CTD PMID:18593933